Johnson & Johnson subsidiary pays $18 million to U.S. in settlement
July 23, 2016 at 16:13 PM EDT
Sarah Mulé WASHINGTON, July 23 (UPI) -- Johnson & Johnson's subsidiary, Acclarent, will pay $18 million to resolve allegations that the company marketed a medical device for use without FDA approval.
